These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6086658)
1. Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor. Parker PJ; Young S; Gullick WJ; Mayes EL; Bennett P; Waterfield MD J Biol Chem; 1984 Aug; 259(15):9906-12. PubMed ID: 6086658 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. Gill GN; Kawamoto T; Cochet C; Le A; Sato JD; Masui H; McLeod C; Mendelsohn J J Biol Chem; 1984 Jun; 259(12):7755-60. PubMed ID: 6330079 [TBL] [Abstract][Full Text] [Related]
3. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Sato JD; Kawamoto T; Le AD; Mendelsohn J; Polikoff J; Sato GH Mol Biol Med; 1983 Dec; 1(5):511-29. PubMed ID: 6094961 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor. Characterization of a monoclonal antibody specific for the receptor of A431 cells. Richert ND; Willingham MC; Pastan I J Biol Chem; 1983 Jul; 258(14):8902-7. PubMed ID: 6306002 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979 [TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to the human epidermal growth factor receptor. Waterfield MD; Mayes EL; Stroobant P; Bennet PL; Young S; Goodfellow PN; Banting GS; Ozanne B J Cell Biochem; 1982; 20(2):149-61. PubMed ID: 6188757 [TBL] [Abstract][Full Text] [Related]
8. A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover. Defize LH; Arndt-Jovin DJ; Jovin TM; Boonstra J; Meisenhelder J; Hunter T; de Hey HT; de Laat SW J Cell Biol; 1988 Sep; 107(3):939-49. PubMed ID: 2458364 [TBL] [Abstract][Full Text] [Related]
9. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. Kawamoto T; Mendelsohn J; Le A; Sato GH; Lazar CS; Gill GN J Biol Chem; 1984 Jun; 259(12):7761-6. PubMed ID: 6330080 [TBL] [Abstract][Full Text] [Related]
10. Purification of an active EGF receptor kinase with monoclonal antireceptor antibodies. Yarden Y; Harari I; Schlessinger J J Biol Chem; 1985 Jan; 260(1):315-9. PubMed ID: 2578126 [TBL] [Abstract][Full Text] [Related]
11. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. Weber W; Bertics PJ; Gill GN J Biol Chem; 1984 Dec; 259(23):14631-6. PubMed ID: 6094567 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. Fernandez-Pol JA J Biol Chem; 1985 Apr; 260(8):5003-11. PubMed ID: 2985573 [TBL] [Abstract][Full Text] [Related]
13. Characterization of site-specific antibodies to the erbB gene product and EGF receptor: inhibition of tyrosine kinase activity. Gentry LE; Lawton A Virology; 1986 Jul; 152(2):421-31. PubMed ID: 3014725 [TBL] [Abstract][Full Text] [Related]
14. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Murthy U; Basu A; Rodeck U; Herlyn M; Ross AH; Das M Arch Biochem Biophys; 1987 Feb; 252(2):549-60. PubMed ID: 2434025 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody reactive with the human epidermal-growth-factor receptor recognizes the blood-group-A antigen. Gooi HC; Schlessinger J; Lax I; Yarden Y; Libermann TA; Feizi T Biosci Rep; 1983 Nov; 3(11):1045-52. PubMed ID: 6198005 [TBL] [Abstract][Full Text] [Related]
16. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. Van de Vijver MJ; Kumar R; Mendelsohn J J Biol Chem; 1991 Apr; 266(12):7503-8. PubMed ID: 2019581 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody (EGR/G49) reactive with the epidermal growth factor receptor of A431 cells recognizes the blood group ALeb and ALey structures. Gooi HC; Picard JK; Hounsell EF; Gregoriou M; Rees AR; Feizi T Mol Immunol; 1985 Jun; 22(6):689-93. PubMed ID: 2991755 [TBL] [Abstract][Full Text] [Related]
18. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. Wu DG; Wang LH; Sato GH; West KA; Harris WR; Crabb JW; Sato JD J Biol Chem; 1989 Oct; 264(29):17469-75. PubMed ID: 2477372 [TBL] [Abstract][Full Text] [Related]
19. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Kawamoto T; Sato JD; Le A; Polikoff J; Sato GH; Mendelsohn J Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1337-41. PubMed ID: 6298788 [TBL] [Abstract][Full Text] [Related]
20. Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Buss JE; Kudlow JE; Lazar CS; Gill GN Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2574-8. PubMed ID: 6283535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]